Tumor-normal sequencing reveals novel TP53 germline and clinically actionable somatic mutations in Nigerian breast cancer patients
Abimbola F. Onyia(Covenant University), Nwamaka Lasebikan(University of Nigeria Teaching Hospital), Oluwakemi A. Rotimi(Covenant University), AbdulRazzaq Oluwagbemiga Lawal(Lagos University Teaching Hospital), Opeyemi C. De Campos(Covenant University), Solomon O. Rotimi(Covenant University), Emeka Iweala(Covenant University), Chidiebere Ogo(Federal Medical Centre), Usman Malami Aliyu(Covenant University), Ebenezer S. Nkom(Federal Medical Centre), Jelili Oyelade(Covenant University), Olaitan T Ayegbusi(Covenant University)
Cited by 2
Related Papers
Bisphenol A in Africa: A review of environmental and biological levels
|The Science of The Total Environment|2020|93
Development of Bioinformatics Infrastructure for Genomics Research
|Global Heart|2017|79
Photosensitizers in photodynamic therapy: An advancement in cancer treatment
|Results in Chemistry|2024|51
GC-MS Analysis and Inhibitory Evaluation of <i>Terminalia catappa</i> Leaf Extracts on Major Enzymes Linked to Diabetes
|Evidence-based Complementary and Alternative Medicine|2019|33